Cargando…

Prevalence of WHO Transmitted Drug Resistance Mutations by Deep Sequencing in Antiretroviral-Naïve Subjects in Hunan Province, China

BACKGROUND: There are few data on the prevalence of WHO transmitted drug resistance mutations (TDRs) that could affect treatment responses to first line antiretroviral therapy (ART) in Hunan Province, China. OBJECTIVE: Determine the prevalence of WHO NRTI/NNRTI/PI TDRs in ART-naïve subjects in Hunan...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiaobai, Zou, Xi, Chen, Tian, Hongping, Williams, Ann B., Wang, Honghong, He, Jianmei, Zhen, Jun, Chiarella, Jennifer, Blake, Lisebeth A., Turenchalk, Gregory, Kozal, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045886/
https://www.ncbi.nlm.nih.gov/pubmed/24896087
http://dx.doi.org/10.1371/journal.pone.0098740
_version_ 1782319402337697792
author Xiaobai, Zou
Xi, Chen
Tian, Hongping
Williams, Ann B.
Wang, Honghong
He, Jianmei
Zhen, Jun
Chiarella, Jennifer
Blake, Lisebeth A.
Turenchalk, Gregory
Kozal, Michael J.
author_facet Xiaobai, Zou
Xi, Chen
Tian, Hongping
Williams, Ann B.
Wang, Honghong
He, Jianmei
Zhen, Jun
Chiarella, Jennifer
Blake, Lisebeth A.
Turenchalk, Gregory
Kozal, Michael J.
author_sort Xiaobai, Zou
collection PubMed
description BACKGROUND: There are few data on the prevalence of WHO transmitted drug resistance mutations (TDRs) that could affect treatment responses to first line antiretroviral therapy (ART) in Hunan Province, China. OBJECTIVE: Determine the prevalence of WHO NRTI/NNRTI/PI TDRs in ART-naïve subjects in Hunan Province by deep sequencing. METHODS: ART-naïve subjects diagnosed in Hunan between 2010–2011 were evaluated by deep sequencing for low-frequency HIV variants possessing WHO TDRs to 1% levels. Mutations were scored using the HIVdb.stanford.edu algorithm to infer drug susceptibility. RESULTS: Deep sequencing was performed on samples from 90 ART-naïve subjects; 83.3% were AE subtype. All subjects had advanced disease (average CD4 count 134 cells/mm(3)). Overall 25.6%(23/90) of subjects had HIV with major WHO NRTI/NNRTI TDRs by deep sequencing at a variant frequency level ≥1%; 16.7%(15/90) had NRTI TDR and 12.2%(11/90) had a major NNRTI TDR. The majority of NRTI/NNRTI mutations were identified at variant levels <5%. Mutations were analyzed by HIVdb.stanford.edu and 7.8% of subjects had variants with high-level nevirapine resistance; 4.4% had high-level NRTI resistance. Deep sequencing identified 24(27.6%) subjects with variants possessing either a PI TDR or hivdb.stanford.edu PI mutation (algorithm value≥15). 17(19.5%) had PI TDRs at levels >1%. CONCLUSIONS: ART-naïve subjects from Hunan Province China infected predominantly with subtype AE frequently possessed HIV variants with WHO NRTI/NNRTI TDRs by deep sequencing that would affect the first line ART used in the region. Specific mutations conferring nevirapine high-level resistance were identified in 7.8% of subjects. The majority of TDRs detected were at variant levels <5% likely due to subjects having advanced chronic disease at the time of testing. PI TDRs were identified frequently, but were found in isolation and at low variant frequency. As PI/r use is infrequent in Hunan, the existence of PI mutations likely represent AE subtype natural polymorphism at low variant level frequency.
format Online
Article
Text
id pubmed-4045886
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-40458862014-06-09 Prevalence of WHO Transmitted Drug Resistance Mutations by Deep Sequencing in Antiretroviral-Naïve Subjects in Hunan Province, China Xiaobai, Zou Xi, Chen Tian, Hongping Williams, Ann B. Wang, Honghong He, Jianmei Zhen, Jun Chiarella, Jennifer Blake, Lisebeth A. Turenchalk, Gregory Kozal, Michael J. PLoS One Research Article BACKGROUND: There are few data on the prevalence of WHO transmitted drug resistance mutations (TDRs) that could affect treatment responses to first line antiretroviral therapy (ART) in Hunan Province, China. OBJECTIVE: Determine the prevalence of WHO NRTI/NNRTI/PI TDRs in ART-naïve subjects in Hunan Province by deep sequencing. METHODS: ART-naïve subjects diagnosed in Hunan between 2010–2011 were evaluated by deep sequencing for low-frequency HIV variants possessing WHO TDRs to 1% levels. Mutations were scored using the HIVdb.stanford.edu algorithm to infer drug susceptibility. RESULTS: Deep sequencing was performed on samples from 90 ART-naïve subjects; 83.3% were AE subtype. All subjects had advanced disease (average CD4 count 134 cells/mm(3)). Overall 25.6%(23/90) of subjects had HIV with major WHO NRTI/NNRTI TDRs by deep sequencing at a variant frequency level ≥1%; 16.7%(15/90) had NRTI TDR and 12.2%(11/90) had a major NNRTI TDR. The majority of NRTI/NNRTI mutations were identified at variant levels <5%. Mutations were analyzed by HIVdb.stanford.edu and 7.8% of subjects had variants with high-level nevirapine resistance; 4.4% had high-level NRTI resistance. Deep sequencing identified 24(27.6%) subjects with variants possessing either a PI TDR or hivdb.stanford.edu PI mutation (algorithm value≥15). 17(19.5%) had PI TDRs at levels >1%. CONCLUSIONS: ART-naïve subjects from Hunan Province China infected predominantly with subtype AE frequently possessed HIV variants with WHO NRTI/NNRTI TDRs by deep sequencing that would affect the first line ART used in the region. Specific mutations conferring nevirapine high-level resistance were identified in 7.8% of subjects. The majority of TDRs detected were at variant levels <5% likely due to subjects having advanced chronic disease at the time of testing. PI TDRs were identified frequently, but were found in isolation and at low variant frequency. As PI/r use is infrequent in Hunan, the existence of PI mutations likely represent AE subtype natural polymorphism at low variant level frequency. Public Library of Science 2014-06-04 /pmc/articles/PMC4045886/ /pubmed/24896087 http://dx.doi.org/10.1371/journal.pone.0098740 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration, which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
spellingShingle Research Article
Xiaobai, Zou
Xi, Chen
Tian, Hongping
Williams, Ann B.
Wang, Honghong
He, Jianmei
Zhen, Jun
Chiarella, Jennifer
Blake, Lisebeth A.
Turenchalk, Gregory
Kozal, Michael J.
Prevalence of WHO Transmitted Drug Resistance Mutations by Deep Sequencing in Antiretroviral-Naïve Subjects in Hunan Province, China
title Prevalence of WHO Transmitted Drug Resistance Mutations by Deep Sequencing in Antiretroviral-Naïve Subjects in Hunan Province, China
title_full Prevalence of WHO Transmitted Drug Resistance Mutations by Deep Sequencing in Antiretroviral-Naïve Subjects in Hunan Province, China
title_fullStr Prevalence of WHO Transmitted Drug Resistance Mutations by Deep Sequencing in Antiretroviral-Naïve Subjects in Hunan Province, China
title_full_unstemmed Prevalence of WHO Transmitted Drug Resistance Mutations by Deep Sequencing in Antiretroviral-Naïve Subjects in Hunan Province, China
title_short Prevalence of WHO Transmitted Drug Resistance Mutations by Deep Sequencing in Antiretroviral-Naïve Subjects in Hunan Province, China
title_sort prevalence of who transmitted drug resistance mutations by deep sequencing in antiretroviral-naïve subjects in hunan province, china
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045886/
https://www.ncbi.nlm.nih.gov/pubmed/24896087
http://dx.doi.org/10.1371/journal.pone.0098740
work_keys_str_mv AT xiaobaizou prevalenceofwhotransmitteddrugresistancemutationsbydeepsequencinginantiretroviralnaivesubjectsinhunanprovincechina
AT xichen prevalenceofwhotransmitteddrugresistancemutationsbydeepsequencinginantiretroviralnaivesubjectsinhunanprovincechina
AT tianhongping prevalenceofwhotransmitteddrugresistancemutationsbydeepsequencinginantiretroviralnaivesubjectsinhunanprovincechina
AT williamsannb prevalenceofwhotransmitteddrugresistancemutationsbydeepsequencinginantiretroviralnaivesubjectsinhunanprovincechina
AT wanghonghong prevalenceofwhotransmitteddrugresistancemutationsbydeepsequencinginantiretroviralnaivesubjectsinhunanprovincechina
AT hejianmei prevalenceofwhotransmitteddrugresistancemutationsbydeepsequencinginantiretroviralnaivesubjectsinhunanprovincechina
AT zhenjun prevalenceofwhotransmitteddrugresistancemutationsbydeepsequencinginantiretroviralnaivesubjectsinhunanprovincechina
AT chiarellajennifer prevalenceofwhotransmitteddrugresistancemutationsbydeepsequencinginantiretroviralnaivesubjectsinhunanprovincechina
AT blakelisebetha prevalenceofwhotransmitteddrugresistancemutationsbydeepsequencinginantiretroviralnaivesubjectsinhunanprovincechina
AT turenchalkgregory prevalenceofwhotransmitteddrugresistancemutationsbydeepsequencinginantiretroviralnaivesubjectsinhunanprovincechina
AT kozalmichaelj prevalenceofwhotransmitteddrugresistancemutationsbydeepsequencinginantiretroviralnaivesubjectsinhunanprovincechina